Aerpio Pharmaceuticals, Inc. - Special Call Transcript
Greetings, and welcome to the Aerpio Pharmaceuticals KOL call on a novel mechanism for the treatment of glaucoma. (Operator Instructions) As a reminder, this conference is being recorded.
I'd now like to turn the conference over to your host, Joseph Gardner, President and Founder of Aerpio Pharmaceuticals. Thank you. You may begin.
Thank you, and thanks, everybody, for participating in this conference call this morning. We're very pleased and excited to be able to present more about our glaucoma program, and we're particularly pleased to have Dr. Paul Kaufman, MD, from the University of Wisconsin, as a presenter; as well as Dr. Janey Wiggs, from Harvard Medical Center, as a presenter as well.
We will be covering the novel mechanism for treating glaucoma. Dr. Kaufman will cover the current landscape and talk about the unmet needs. Dr. Wiggs will talk about the role of the Tie2 receptor in maintaining intraocular pressure. And I will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
